Only Available By Prescription
Sign up to get notified if we do in the future.
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Retatrutide is an investigational injection that is currently being researched as a treatment for obesity and type 2 diabetes. It is classified as a triple agonist because it works on three different hormone receptors at the same time: GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and glucagon. As a result, the drug may help reduce appetite and improve blood sugar control. Retatrutide has not received approval from the U.S. Food and Drug Administration (FDA), Health Canada, or any other regulatory agency as of 2026, and it can only be obtained through clinical trials at this time.
| Fact Table |
|
| Formula |
C221H342N46O68 |
| License |
None; investigational, not FDA approved |
| Bioavailability |
Not available |
| Legal status |
Investigational; clinical-trial use only |
| Chemical Name |
Retatrutide (LY3437943) |
| Elimination half-life |
Approximately 6 days |
| Dosage (Strength) |
No approved dosage; clinical trials studied 1 mg, 4 mg, 8 mg, 12 mg once weekly subcutaneously; Phase 3 trials also studied 4 mg, 9 mg, 12 mg once weekly |
| Pregnancy |
Safety not established; avoid outside clinical-trial protocol |
| Brands |
None |
| Protein binding |
Not available |
| PubChem CID |
171390338 |
| MedlinePlus |
Not available |
| ChEBI |
Not available |
| ATC code |
Not assigned |
| DrugBank |
DB18993 |
| KEGG |
D12430 |
| Routes of administration |
Subcutaneous injection |
Retatrutide should be used only within an approved clinical study or as instructed by a healthcare provider. During phase 2 studies, the drug was administered as an injection under the skin once per week, in the stomach, thigh, or upper arm, and on the same day each week. The starting dose is usually 2 mg weekly, which is then gradually raised over a number of weeks to 4 mg, 8 mg, or 12 mg.
If a dose is missed, patients should follow their provider’s guidance and never inject two doses together. Retatrutide is designed to be used alongside a lower-calorie diet and physical activity.
The active ingredient is retatrutide.
Before starting this medication, it may be helpful to talk with a healthcare provider about:
Retatrutide should be taken only with medical oversight, since its long-term safety has not been fully established.
Research found that larger doses of retatrutide raised heart rate, with the effect peaking near the 24-week mark. Your healthcare provider may monitor your heart rate and blood pressure, particularly if you have a heart condition.
Digestive side effects such as nausea, vomiting, and diarrhea happen often, especially when beginning treatment or moving to a higher dose. Ongoing or severe vomiting and diarrhea can cause dehydration, which may harm the kidneys.
In people with type 2 diabetes who also take insulin or drugs that boost insulin output, the chance of low blood sugar, also called hypoglycemia, may be increased. A healthcare provider may need to reduce the dose of those medications.
Drugs in the GLP-1 receptor agonist family have been associated with pancreatitis, or inflammation of the pancreas, and gallbladder problems. Get medical attention for intense stomach pain, fever, or yellowing of the eyes or skin.
Since retatrutide slows the rate at which the stomach empties, it can change how food and other oral medicines are absorbed.
Like similar medications and the criteria used to enroll patients in clinical trials, retatrutide should not be used by anyone who:
In clinical trials, the side effects reported most often with retatrutide are gastrointestinal. They are typically mild to moderate and tend to show up when treatment begins or the dose increases. Possible side effects include:
Because retatrutide is still under investigation, its full range of serious side effects may not yet be understood. Seek medical attention if you notice signs of a serious allergic reaction, including difficulty breathing, a bad rash, or swelling of the face, lips, tongue, or throat. Get urgent care for severe or lasting abdominal pain, particularly if it radiates to the back, which may indicate pancreatitis. Reach out to your provider if you experience heavy vomiting or diarrhea, or symptoms of low blood sugar such as trembling, sweating, confusion, or a racing heartbeat. Also, let your provider know about any new lump or swelling in the neck, a hoarse voice, or difficulty swallowing.
What is Retatrutide?
Retatrutide is an investigational injectable medication being studied for weight management, obesity, type 2 diabetes, and related metabolic conditions. It is not currently approved for routine medical use.
How does Retatrutide work?
Retatrutide works by activating three hormone receptors involved in metabolism: GLP-1, GIP, and glucagon receptors. These actions may help reduce appetite, improve blood sugar control, and support weight loss.
What conditions is Retatrutide being studied for?
Retatrutide is being studied mainly for obesity, overweight with related health conditions, type 2 diabetes, and metabolic liver conditions such as MASH, also known as metabolic dysfunction-associated steatohepatitis.
Is Retatrutide approved by the FDA?
Retatrutide is still considered investigational and has not been approved by the FDA for general prescription use. It may only be available through clinical trials or specific research programs.
How is Retatrutide taken?
Retatrutide is being studied as a once-weekly injection under the skin. The exact dose and treatment schedule depend on the clinical trial protocol or healthcare provider guidance.
What are the common side effects of Retatrutide?
Common side effects reported in studies may include nausea, vomiting, diarrhea, constipation, decreased appetite, indigestion, and abdominal discomfort. Side effects may vary depending on the dose and individual response.
Can Retatrutide help with weight loss?
Clinical studies have shown that Retatrutide may lead to significant weight loss in some individuals. However, more research is needed to confirm its long-term safety, effectiveness, and appropriate use.
Who should not take Retatrutide?
Because Retatrutide is investigational, its full safety profile is still being studied. People with certain medical conditions, a history of pancreatitis, gallbladder disease, or endocrine disorders should discuss potential risks with a healthcare professional before participating in a trial.
Can Retatrutide be taken with other medications?
Retatrutide may interact with medications that affect blood sugar, such as insulin or sulfonylureas, and may increase the risk of low blood sugar when used together. Always inform your healthcare provider about all medications, supplements, and herbal products you take.
Is Retatrutide available for purchase?
Retatrutide is not approved for commercial sale and should not be purchased from unverified sources. Products advertised online as Retatrutide may be unsafe, counterfeit, or not intended for human use.
Exceptional Customer Service
We pride ourselves on delivering excellent customer service with as much accessibility as possible.
If you have any questions at all, or would like to place an order, you are encouraged to contact us by toll-free
phone 1-888-904-8467 or email info@canadadrugsdirect.com.
Top Safety and Quality
Canada Drugs Direct employs dedicated, professional licensed pharmacists to ensure that each and every order is reviewed before it is dispensed for the safety and health of our customers. At CanadaDrugsDirect.com, your health is our top priority.
Product Reviews